Objective: Cervical spinal cord (cSC) gray matter (GM) damage is associated with current disability in multiple sclerosis (MS), but its prognostic value remains unexplored. We aimed to investigate whether cSC GM damage may predict disability worsening in MS.
Materials And Methods: Seventy-nine MS patients and 49 healthy controls (HC) underwent 3 T brain and cSC MRI at baseline and two neurological evaluations after median follow-up of 1.3 years. Total and GM cSC lesions were identified on axial T2-weighted sequences, whereas global and GM cSC cross-sectional areas (CSAs) at C3-C4 level were quantified on phase-sensitive inversion recovery sequences. Brain lesional and volumetric measures were also assessed. At follow-up, disability worsening was defined as deterioration on ≥ 1/3 components of the Expanded Disability Status Scale (EDSS)-plus score (EDSS worsening or ≥ 20% change in timed 25-foot walk [T25FWT] or 9-hole peg test [9-HPT]).
Results: At follow-up, 40/79 (50.6%) patients showed EDSS-plus worsening, with 13/79 (16.4%) worsening at EDSS score, 13/79 (16.4%) at 9-HPT, and 29/79 (36.7%) at T25FWT. Progressive phenotype (odds ratio [OR] = 8.65) predicted EDSS worsening (p = 0.001, C-index = 0.79). Progressive phenotype (OR = 5.56), lower cortical volume (OR = 0.41), and higher cSC GM T2-hyperintense lesion volume (OR = 2.28) (p ≤ 0.035, C-index = 0.88) predicted 9-HPT worsening. Longer disease duration (OR = 1.64), progressive phenotype (OR = 4.74), and lower cSC GM CSA (OR = 0.51) predicted T25FWT worsening (p ≤ 0.050, C-index = 0.77). Male sex (OR = 6.12), older age (OR = 1.71), progressive phenotype (OR = 7.40), and lower cSC GM CSA (OR = 0.47) predicted EDSS-plus worsening (p ≤ 0.055, C-index = 0.83).
Conclusions: cSC GM damage emerged as a relevant MRI predictor of disability worsening in MS, highlighting its prognostic relevance.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00415-025-12979-4 | DOI Listing |
Asia Pac J Public Health
March 2025
Department of Rehabilitation Medicine, Tokyo Bay Rehabilitation Hospital, Chiba, Japan.
In 2020, the coronavirus disease 2019 (COVID-19) pandemic altered lifestyles dramatically. We previously reported that the physical function of walk-in rehabilitation users in Japan worsened after the state of emergency declaration and continued to worsen until the end of 2020. However, whether physical function continued to worsen during the prolonged pandemic period remains unclear.
View Article and Find Full Text PDFBMC Psychiatry
March 2025
Staten Island University Hospital, Staten Island, NY, USA.
Background: Mental disorders are a major public health issue, causing 4.9% of global disability-adjusted life years (DALYs). In Jordan, factors like regional conflicts, economic changes, and population growth contribute to this burden.
View Article and Find Full Text PDFCochrane Database Syst Rev
March 2025
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Background: Multiple sclerosis (MS) is the most common neurological cause of disability in young adults. Off-label rituximab for MS is used in most countries surveyed by the International Federation of MS, including high-income countries where on-label disease-modifying treatments (DMTs) are available. This updates the 2021 version of the review.
View Article and Find Full Text PDFBMC Musculoskelet Disord
March 2025
Department of Rehabilitation, University Hospital Brno, Brno, Czech Republic.
Background: Chronic low back pain (CLBP) is one of the most common musculoskeletal problems worldwide. Even though regular exercise is recommended as the primary conservative approach in treating this condition, significant part of patients lead sedentary lifestyle. Motivation to exercise is one of the variables that effects the adherence of exercise-based treatments.
View Article and Find Full Text PDFJ Neurol Neurosurg Psychiatry
March 2025
Department of Neurology, Justus-Liebig-University Giessen, Giessen, Germany
Background: The impact of body weight on disability progression rates among patients receiving ofatumumab was not evaluated yet.
Methods: Among patients from a multicentre prospective cohort, baseline demographics were compared among body mass index (BMI) quartiles as well as proportions of clinical relapses, MRI lesions and disability worsening during follow-up.
Results: 536 patients from four centres were included.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!